ERA4TB accelerates the development of new treatment regimens for tuberculosis.

Effects of the COVID-19 on the fight against tuberculosis

The general public is well aware of the tragic impact of the COVID-19 on the community in terms of lives, disruption of livelihoods and social distress. Far less obvious are the indirect effects that the outbreak exert on other major diseases of global incidence like tuberculosis. To contain the spread of the COVID-19, most countries have imposed strict lockdown measures that, however necessary, are negatively affecting the programs to eradicate tuberculosis at global level by hindering TB diagnosis, notifications and likely shortening the provision of drugs against the infection.

The Stop-TB Partnership has been working on a series of models to estimate the effect of the COVID-19 outbreak on the progress of TB at global scale. These models focus on three countries with a high burden of TB and distinct social settings that constitute paradigmatic cases within the spectrum of countries in which TB has a high incidence. In the worst-case scenario, the modelers estimated that a 3-month lockdown followed by a 10-month period to return to normality could lead to an additional 6.3 million cases of TB between 2020 and 2025, and an additional 1.4 million TB deaths during this time at global level. With these figures, the gains made in the fight against TB in the last five to eight years could be lost out. The study stresses that recovering the progress made in the last years will only be possible through increasing the efforts and investments in TB.

ERA4TB stands in solidarity with the additional difficulties that the present situation imposes on patients and professionals involved in treating TB. ERA4TB is committed with the development of new drugs of easy administration and effectivity against resistant strains, the consortium hopes to help mitigate the consequences of the COVID-19 outbreak on the battle against TB.

ERA4TB (European Regimen Accelerator for Tuberculosis) project is a public-private initiative devoted to accelerate the development of new treatment regimens for tuberculosis.

Objectives

The main objective of ERA4TB is to create a European open platform to accelerate the development of new regimens for the treatment of tuberculosis.

Ambition

All Member States of WHO and the UN have committed to the goal of ending the TB epidemic by 2030 through their unanimous endorsement of WHO’s End TB Strategy at the World Health Assembly and their adoption of the UN Sustainable Development Goals (SDGs).

Ambition

All Member States of WHO and the UN have committed to the goal of ending the TB epidemic by 2030 through their unanimous endorsement of WHO’s End TB Strategy at the World Health Assembly and their adoption of the UN Sustainable Development Goals (SDGs).

Structure

The ERA4TB platform is based on a progression pipeline that can cater for a variety of molecules at different stages of development.

News

Follow our articles and ERA4TB news

News

ERA4TB welcomes CIM – Sant Pau (IIB Sant Pau) as New Partner

ERA4TB announced on the 4th Consortium Meeting that CIM – Sant Pau (IIB Sant Pau)…
News

The ERA4TB Scientific Advisory Board has been set up

Dr Gilla Kaplan, Ph.D. Former Director of the Global Health Program, Tuberculosis, at the Bill…
Event

ERA4TB 4th Consortium Meeting: The Time to Make a Difference

On the 27th and 28th of January 2022, Consortium members gathered virtually for two days…

Twitter

Follow us and be the first
to know what we do

The @IHIEurope @AMRAccelerator is a public-private partnership of 9 projects united to fight #AMR and #TB. Our #newsletter provides the best summary. Already sign up now and receive the next issue in your inbox: https://bit.ly/3vQ2bMX

#HealthForAll #OneHealth #StopSuperbugs

The @IHIEurope @AMRAccelerator is all about public-private partnerships to tackle #TB and #AMR. Do you want to get an overview on what's new from all projects?Sign up to our newsletter and receive the next issue in your inbox: https://bit.ly/3vQ2bMX

#OneHealth #StopSuperbugs

New @WHO guidelines have the potential to transform the TB treatment landscape with six-month standard. Read more from our statement on the WHO's Rapid Communication for drug-resistant #tuberculosis treatment: https://bit.ly/TBA-WHO-DR-TB #EndTB

Are you at the @AMR_Conference today? 🏃 🏃 🏃 Go quick to the media table in the exhibition to grab your copy of the freshly printed @IMI_ERA4TB info sheet! The pile is getting smaller and smaller https://amr-accelerator.eu/project/era4tb/ #StopAMR #AntimicrobialResearch

Load More...

Know how accelerate the development of new treatment regimens for tuberculosis, discover our project

The Project